Sopharma AD (WSE:SPH)
Poland flag Poland · Delayed Price · Currency is PLN
12.05
0.00 (0.00%)
Apr 29, 2025, 10:24 AM CET

Sopharma AD Company Description

Sopharma AD produces, distributes, and exports pharmaceutical products in Europe, Bulgaria, and internationally.

It offers Carsil to treat liver disease; Tempalgin, a painkiller; Analgin, a pain reliever; Tabex, a drug used for smoking secession; Tribestan, a drug used for stimulation of the male reproductive system; Broncholytin, which is used to suppress cough; Nivalin for use in the peripheral nervous system; Methylprednisolon for severe allergies and life-threatening conditions; Vitamin C; Valeriana to reduce the stress; and medical devices, such as gauzes, compresses, and dressing.

The company also provides food supplements; medicinal and cosmetic products, including plasters, bandages, herbal cosmetics, and sanitary-hygiene products; concentrates for hemodialysis; and prescription medicines, and OTC and veterinary medical products.

In addition, the company distributes pharmaceuticals, medical supplies, sanitary materials, vitamins, food supplements, and cosmetics; and provides contract manufacturing services; packaging services; and product development services.

Further, it is involved in trading of pharmaceuticals; trades, transports, and packages radioactive materials and nuclear equipment for medicinal use, household electronics, and electrical equipment; purchases, grows, produces, and trades in herbs and medicinal plant; and provision of public opinion research services.

Additionally, the company engages in the offline and online retail trade of medicinal products and medical equipment; and franchising, know-how, and rental of properties, as well as in trading, consulting, and other activities.

Sopharma AD was founded in 1933 and is headquartered in Sofia, Bulgaria.

Sopharma AD
Country Bulgaria
Founded 1933
Industry Medical Distribution
Sector Healthcare
Employees 5,599
CEO Ognian Donev

Contact Details

Address:
16, Iliensko Shousse St.
Sofia, 1220
Bulgaria
Phone 359 28 13 42 00
Website sopharmagroup.com

Stock Details

Ticker Symbol SPH
Exchange Warsaw Stock Exchange
Fiscal Year January - December
Reporting Currency BGN
ISIN Number BG11SOSOBT18
SIC Code 2834

Key Executives

Name Position
Ognian Ivanov Donev D.Sc. (Econ.), Ph.D. Chairman, Chief Executive Officer and MD
Boris Anchev Borisov Chief Financial Officer and Financial Director
Iordanka Nikolova Petkova Chief Accountant
Pelagia Stefanova Viatcheva Director of Investor Relations
E. Joffe Director of Quality Management and Regulatory Compliance
Alexandar Yotov Head of Legal Department
E. Krasteva Director of Advertising and Corporate Communications
Lyudmila Bondzhova Head of Reporting Department
E. Mihailova Head of Production Division
S. Katzarova Head of Regulatory Affairs Bulgaria and Third Markets Division